ATI RN
ATI N180 Pharmacology Exam Questions
Extract:
Question 1 of 5
Which of the following medications are parenteral anti-diabetic medications used to treat clients with type 2 diabetes mellitus that are administered via the subcutaneous route? (Select All That Apply.).
Correct Answer: A,B
Rationale: The correct answers are A: NPH Insulin (Humulin N) and B: Regular insulin (Humulin R). These are parenteral anti-diabetic medications administered subcutaneously. Insulin is a hormone that regulates blood sugar levels in type 2 diabetes. NPH and Regular insulins are both short-acting insulins that help control blood sugar levels by mimicking the body's natural insulin production.
Choices C, D, and the remaining options are incorrect because Glipizide and Metformin are oral anti-diabetic medications that are not administered through the subcutaneous route. Glipizide is a sulfonylurea that stimulates insulin secretion, and Metformin is a biguanide that decreases glucose production in the liver.
Therefore, choices C, D, and the other options are not parenteral anti-diabetic medications administered subcutaneously.
Question 2 of 5
Correct Answer:
Rationale:
Question 3 of 5
Correct Answer:
Rationale:
Question 4 of 5
Correct Answer:
Rationale:
Question 5 of 5
Correct Answer:
Rationale: